Quincy Bioscience is a research-based biotechnology company
Quincy Bioscience is a biotechnology company based in Madison, Wisconsin focused on the discovery, development and commercialization of novel technologies to support cognitive function and other normal health challenges such as mild memory problems associated with aging.
Quincy Bioscience is set apart by its use of apoaequorin, originally discovered in jellyfish, now patented by Quincy Bioscience for use in a variety of products to support cognitive function. Apoaequorin is manufactured in a cGMP compliant facility.
The discovery and development of Apoaequorin in 1962 earned the scientists responsible the Nobel Prize in Chemistry in 2008. Quincy Bioscience is building on this work through its novel use of Apoaequorin. Apoaequorin achieved self-affirmed GRAS status (generally recognized as safe) after an independent panel of expert scientists concluded that apoaequorin is safe for use in food products.
Prevagen® is the company’s flagship consumer brand containing apoaequorin. A landmark double-blind and placebo-controlled trial demonstrated Prevagen’s strong relationship with improvements on quantitative measures of cognitive function, specifically verbal learning.*
Prevagen is now the number one selling brain support supplement in chain pharmacies across America according to Nielsen data (March, 2016).
Prevagen is 100% manufactured in the United States
Quincy Bioscience’s Quality Assurance Department follows current Good Manufacturing Practice (cGMP) requirements for dietary supplements as defined in federal code by 21 CFR 111. All batches are tested for purity, strength, and safety.